FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.61), $0.10 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $15.79 million.
For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.
... More
